A while ago I presented a cautious population health perspective on the potential impact of modern genomics, ending with the observation that:
It is not anti-scientific to worry that our American belief in technology and venture capitalism could result in much waste, while less expensive investments we already know to be effective are ignored. The problem is that it is hard to predict the future, and decades from now there will certainly be important benefits from genomic research, including both treatments and preventive interventions. We can only insist that the most careful evidence on population health cost-effectiveness be used to guide investments, rather than the potential for profit from very expensive therapies that benefit few.
But what to make of this quote I came upon the other day from Duke University geneticist Randy Jirtle?